These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 26363866)

  • 1. New multifunctional melatonin-derived benzylpyridinium bromides with potent cholinergic, antioxidant, and neuroprotective properties as innovative drugs for Alzheimer's disease.
    Luo XT; Wang CM; Liu Y; Huang ZG
    Eur J Med Chem; 2015 Oct; 103():302-11. PubMed ID: 26363866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties.
    Fernández-Bachiller MI; Pérez C; Campillo NE; Páez JA; González-Muñoz GC; Usán P; García-Palomero E; López MG; Villarroya M; García AG; Martínez A; Rodríguez-Franco MI
    ChemMedChem; 2009 May; 4(5):828-41. PubMed ID: 19308922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel cinnamamide-dibenzylamine hybrids: Potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.
    Wang J; Cai P; Yang XL; Li F; Wu JJ; Kong LY; Wang XB
    Eur J Med Chem; 2017 Oct; 139():68-83. PubMed ID: 28800459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
    Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
    Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
    Li Y; Qiang X; Li Y; Yang X; Luo L; Xiao G; Cao Z; Tan Z; Deng Y
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2035-9. PubMed ID: 26947607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
    Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
    Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease.
    Li SY; Wang XB; Xie SS; Jiang N; Wang KD; Yao HQ; Sun HB; Kong LY
    Eur J Med Chem; 2013 Nov; 69():632-46. PubMed ID: 24095756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional tacrine-trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties.
    Xie SS; Lan JS; Wang XB; Jiang N; Dong G; Li ZR; Wang KD; Guo PP; Kong LY
    Eur J Med Chem; 2015 Mar; 93():42-50. PubMed ID: 25656088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties.
    Cai P; Fang SQ; Yang HL; Yang XL; Liu QH; Kong LY; Wang XB
    Eur J Med Chem; 2018 Sep; 157():161-176. PubMed ID: 30096650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin.
    Wang J; Wang ZM; Li XM; Li F; Wu JJ; Kong LY; Wang XB
    Bioorg Med Chem; 2016 Sep; 24(18):4324-4338. PubMed ID: 27460699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzofuran-derived benzylpyridinium bromides as potent acetylcholinesterase inhibitors.
    Baharloo F; Moslemin MH; Nadri H; Asadipour A; Mahdavi M; Emami S; Firoozpour L; Mohebat R; Shafiee A; Foroumadi A
    Eur J Med Chem; 2015 Mar; 93():196-201. PubMed ID: 25681712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New benzyl pyridinium derivatives bearing 2,4-dioxochroman moiety as potent agents for treatment of Alzheimer's disease: Design, synthesis, biological evaluation, and docking study.
    Mollazadeh M; Mohammadi-Khanaposhtani M; Zonouzi A; Nadri H; Najafi Z; Larijani B; Mahdavi M
    Bioorg Chem; 2019 Jun; 87():506-515. PubMed ID: 30928873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel salicylamide derivatives as potent multifunctional agents for the treatment of Alzheimer's disease: Design, synthesis and biological evaluation.
    Song Q; Li Y; Cao Z; Qiang X; Tan Z; Deng Y
    Bioorg Chem; 2019 Mar; 84():137-149. PubMed ID: 30500523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New melatonin-N,N-dibenzyl(N-methyl)amine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.
    López-Iglesias B; Pérez C; Morales-García JA; Alonso-Gil S; Pérez-Castillo A; Romero A; López MG; Villarroya M; Conde S; Rodríguez-Franco MI
    J Med Chem; 2014 May; 57(9):3773-85. PubMed ID: 24738476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer's disease.
    Lan JS; Hou JW; Liu Y; Ding Y; Zhang Y; Li L; Zhang T
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):776-788. PubMed ID: 28585866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease.
    Wang D; Hu M; Li X; Zhang D; Chen C; Fu J; Shao S; Shi G; Zhou Y; Wu S; Zhang T
    Eur J Med Chem; 2019 Apr; 168():207-220. PubMed ID: 30822710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
    Singh YP; Shankar G; Jahan S; Singh G; Kumar N; Barik A; Upadhyay P; Singh L; Kamble K; Singh GK; Tiwari S; Garg P; Gupta S; Modi G
    Bioorg Med Chem; 2021 Sep; 46():116385. PubMed ID: 34481338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine.
    Huang G; Kling B; Darras FH; Heilmann J; Decker M
    Eur J Med Chem; 2014 Jun; 81():15-21. PubMed ID: 24819955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-Meptazinol-melatonin hybrids as novel dual inhibitors of cholinesterases and amyloid-β aggregation with high antioxidant potency for Alzheimer's therapy.
    Cheng S; Zheng W; Gong P; Zhou Q; Xie Q; Yu L; Zhang P; Chen L; Li J; Chen J; Chen H; Chen H
    Bioorg Med Chem; 2015 Jul; 23(13):3110-8. PubMed ID: 26025073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of novel xanthone-alkylbenzylamine hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Zhang Z; Guo J; Cheng M; Zhou W; Wan Y; Wang R; Fang Y; Jin Y; Liu J; Xie SS
    Eur J Med Chem; 2021 Mar; 213():113154. PubMed ID: 33476932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.